# ğŸ“… Daily Report - 2026-01-08

> ä»Šæ—¥ç­›é€‰å‡º **52** æ¡å†…å®¹ï¼Œæ¥è‡ª **3** ä¸ªæ¥æº

<div class="powered-by-top">Powered by <a href="https://kyplus.de">ç§‘ç ”æ™®æ‹‰æ–¯</a> & <a href="https://claude.ai">Claude</a></div>

---

## ğŸ¤– ä»Šæ—¥AIæ™ºèƒ½æ€»ç»“

### ğŸ§¬ æ•°æ®å‰æ²¿

> **ä»Šæ—¥ç„¦ç‚¹**ï¼š
FAKæŠ‘åˆ¶å‰‚é‡Šæ”¾Omega-3è„‚è‚ªé…¸ï¼Œæ¿€æ´»å·¨å™¬ç»†èƒäº§ç”ŸCXCL13ï¼Œå¢å¼ºåµå·¢ç™Œå…ç–«æ²»ç–—æ•ˆæœï¼›HDAC7ä»‹å¯¼çš„ç»„è›‹ç™½é‡ç¼–ç¨‹é©±åŠ¨ç™Œç»†èƒå¼‚æŸ“è‰²è´¨æ‰©æ•£ã€‚

**ä¸»è¦æ–¹å‘**ï¼š
- è‚¿ç˜¤å…ç–«ä¸ä¿¡å·é€šè·¯è°ƒæ§ï¼ˆå¦‚FAKã€CSF3ã€Oncostatin Måœ¨ç™Œç—‡åŠç‚ç—‡ä¸­çš„ä½œç”¨ï¼‰ã€‚
- è¡¨è§‚é—ä¼ æœºåˆ¶åœ¨ç™Œç—‡å‘ç”Ÿå‘å±•ä¸­çš„ä½œç”¨ï¼ˆå¦‚HDAC7ã€BAP1ã€KMT2Aã€EGFR DNAæ‹·è´æ•°æ‰©å¢ï¼‰ã€‚
- ç»†èƒåˆ†åŒ–ã€å¼‚è´¨æ€§åŠä»£è°¢é‡å¡‘ï¼ˆå¦‚ç”²çŠ¶è…ºç™Œã€èƒšèƒå¶ã€è‚ é“å¹²ç»†èƒã€å·¨å™¬ç»†èƒï¼‰ã€‚

**æŠ€æœ¯äº®ç‚¹**ï¼š
- ç©ºé—´è½¬å½•ç»„å­¦æŠ€æœ¯åº”ç”¨äºæ¤ç‰©ï¼ˆç‰ç±³ï¼‰ç ”ç©¶ã€‚
- å¤šç§é«˜é€šé‡æµ‹åºæŠ€æœ¯ï¼ˆRNA-seq, ChIP-seq, ATAC-seqï¼‰è”åˆåº”ç”¨äºæ·±å…¥è§£æè¡¨è§‚é—ä¼ è°ƒæ§ã€‚

### ğŸ“Š å­¦ç‚¹ç”Ÿä¿¡

> **ä»Šæ—¥ç„¦ç‚¹**ï¼š
LazyMouse é¦–æ¬¡æ¨å‡º R åŒ…ï¼Œåˆ©ç”¨éšæœºé¼ æ ‡ç§»åŠ¨åŠŸèƒ½æå‡ R ç”¨æˆ·ä½“éªŒã€‚

**ä¸»è¦æ–¹å‘**ï¼š
- æå‡ R IDE ç”¨æˆ·äº¤äº’ä½“éªŒ
- è‡ªåŠ¨åŒ–é¼ æ ‡æ“ä½œä»¥å‡å°‘é‡å¤æ€§å·¥ä½œ

**æŠ€æœ¯äº®ç‚¹**ï¼š
- **æ–°å‹ R åŒ… LazyMouse**ï¼šæä¾›å•ä¸€å‡½æ•°å®ç°é¼ æ ‡å…‰æ ‡çš„éšæœºç§»åŠ¨ã€‚

### ğŸ§ª åšå®¢æ›´æ–°

> **ä»Šæ—¥ç„¦ç‚¹**ï¼š
æ–°å‹ç£æ€§çº³ç±³ææ–™å®ç°éª¨ç™Œæ²»ç–—ä¸éª¨å†ç”ŸåŒé‡åŠŸæ•ˆï¼›å•ç»†èƒå¤šç»„å­¦æŠ€æœ¯é¦–æ¬¡å°†é—ä¼ å˜å¼‚ä¸ç»†èƒç±»å‹è°ƒæ§ç½‘ç»œå…³è”ã€‚

**ä¸»è¦æ–¹å‘**ï¼š
- è‚ é“ç»†èŒäº§ç‰©ä¸å¸•é‡‘æ£®ç—…å‘ç”Ÿæœºåˆ¶ç ”ç©¶ã€‚
- å…¨çƒç™Œç—‡å‘ç—…ç‡åŠæ­»äº¡ç‡æ˜¾è‘—ä¸Šå‡è¶‹åŠ¿ã€‚
- RNAå‰ªæ¥ä¸åŠ å·¥åœ¨äººä½“è¡°è€ä¸­çš„æ ¸å¿ƒä½œç”¨ã€‚

**æŠ€æœ¯äº®ç‚¹**ï¼š
- æ•´åˆå•ç»†èƒRNAæµ‹åºã€æŸ“è‰²è´¨æ•°æ®ä¸GWASä¿¡å·ï¼Œæ„å»ºç»†èƒç‰¹å¼‚æ€§è°ƒæ§ç½‘ç»œã€‚
- ç£æ€§çº³ç±³ææ–™åœ¨ç£åœºä¸‹åŠ çƒ­ï¼ŒååŒæ€ä¼¤è‚¿ç˜¤ç»†èƒå¹¶ä¿ƒè¿›éª¨ç»„ç»‡ä¿®å¤ã€‚

---

## ğŸ“š åˆ†ç±»æµè§ˆ

<details>
<summary style="text-align: right; direction: rtl; padding: 10px 15px; background: linear-gradient(135deg, #f8f9fa 0%, #e9ecef 100%); border-right: 4px solid #667eea; font-weight: 600; cursor: pointer; margin: 15px 0; border-radius: 6px;">ğŸ§¬ æ•°æ®å‰æ²¿ (46æ¡)</summary>

<div class="details-content" markdown="1">

#### è¯¦ç»†å†…å®¹ï¼ˆå‰10æ¡ï¼‰

**1.** â­ **GSE313445 åµå·¢è‚¿ç˜¤ FAK æŠ‘åˆ¶å‰‚é‡Šæ”¾ Omega-3 è„‚è‚ªé…¸åˆºæ¿€ GATA6 è…¹è†œå·¨å™¬ç»†èƒäº§ç”Ÿ CXCL13 å¢å¼ºå…ç–«ç–—æ³•**
- âœï¸ **ä½œè€…**ï¼šæœªçŸ¥ä½œè€…
- ğŸ·ï¸ **å…³é”®è¯**ï¼štumorã€macrophageã€regex:immuno(logy|therapy|suppression)
- ğŸ“ **æè¿°**ï¼šContributors : Dwayne Stupack ; Duygu Ozmadenci ; David Schlaepfer ; James LeeSeries Type : Expression profiling by high throughput sequencingOrganism : Mus musculusGenetic or pharmacolgic inhibition of Focal Adhesion Kinase in the murine KMF tumor model is compared to the growth of untreated tumors and with those treated with first line or second line chemotherapies. Impact upon the tumor subpopulations and immune compartment is evaluated via scRNAseq..
- ğŸ”— [æŸ¥çœ‹åŸæ–‡](http://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE313445)

**2.** â­ **GSE196882 ç‰ç±³èƒšå¶çš„ç©ºé—´è½¬å½•ç»„å­¦**
- âœï¸ **ä½œè€…**ï¼šæœªçŸ¥ä½œè€…
- ğŸ·ï¸ **å…³é”®è¯**ï¼šspatialã€spatial transcriptomicsã€transcriptomics
- ğŸ“ **æè¿°**ï¼šContributor : Chi-Chih WuSeries Type : Expression profiling by high throughput sequencing ; OtherOrganism : Zea maysTo explore spatial genetic profiling with histological and cellular features, we conducted 10x Visium transcriptomic system from 8 maize seedling shoots, comprising SAM and serial 5 developing embryonic leaves.
- ğŸ”— [æŸ¥çœ‹åŸæ–‡](http://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE196882)

**3.** â­ **GSE311419 è§£æ BRAFV600E é©±åŠ¨çš„å°é¼ ç”²çŠ¶è…ºç™Œä¸­çš„åŠŸèƒ½æ€§è‚¿ç˜¤å†…å¼‚è´¨æ€§ï¼Œæ­ç¤º EMT è½¨è¿¹å’Œä»£è°¢é‡å¡‘**
- âœï¸ **ä½œè€…**ï¼šæœªçŸ¥ä½œè€…
- ğŸ·ï¸ **å…³é”®è¯**ï¼šcancerã€metabolicã€trajectory
- ğŸ“ **æè¿°**ï¼šContributors : Hao Ying ; Ling Zhang ; Siyi Shen ; Jing YuSeries Type : Expression profiling by high throughput sequencingOrganism : Mus musculusA better understanding of functional heterogeneity of tumor cells may lead to the improvement of the diagnosis and development of effective therapies for patients with papillary thyroid cancer (PTC). Here, the transcriptional heterogeneity and hierarchical trajectory of malignant thyrocytes were investigated by single-cell RNA sequencing analysis in an adult-onset autochthonous mouse model of PTC driven by a BRAFV600E. Within BRAFV600E thyrocytes, we identified distinct subpopulations exhibiting varying degrees of mesenchymal transformation and stability. Further analysis uncovered an epithelial-mesenchymal transition (EMT) trajectory, where malignant subpopulations progress from an intermediate to a more mesenchymal and malignant state. The EMT-related phenotype of each subpopulation was validated with an organoid culture system. Further analysis demonstrated that major malignant subpopulations maintain distinct EMT states through subpopulation-specific pathway usage, whereas transitioning cells undergo a dynamic shift in molecular strategy by using different pathway combinations or distinct gene sets within the same EMT-related pathways along the EMT trajectory. Moreover, metformin diminished the most malignant subpopulation in the PTC mouse model and inhibited EMT potential in both regular and organoid cultures. Importantly, the functional heterogeneity of tumor cells identified in PTC mouse model have clinical relevance. Furthermore, transcriptome dynamics analysis revealed an EMT trajectory-related gene module with substantial predictive value for human PTCs with BRAFV600E. Lastly, our analysis reveals that p53 deficiency lowers the tumorigenic threshold for BRAFV600E and promotes cell state transition towards a more malignant state, rather than altering cellular heterogeneity or the transition trajectory. Subsequent analysis in vitro demonstrated that p53 loss might confer more malignant potential to BRAFV600E thyrocytes through modulating metabolic plasticity. Collectively, our work not only deciphers the functional intra-tumoral heterogeneity of BRAFV600E-drieven PTC but also thereby provides a theoretical foundation for developing EMT-targeted treatment.
- ğŸ”— [æŸ¥çœ‹åŸæ–‡](http://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE311419)

**4.** â­ **GSE286177 å¼‚æŸ“è‰²è´¨åœ¨ç™Œç»†èƒä¸­é€šè¿‡ HDAC7 ä»‹å¯¼çš„ç»„è›‹ç™½ H3.3 ç»“æ„é‡ç¼–ç¨‹æ‰©æ•£ [RNA-seq]**
- âœï¸ **ä½œè€…**ï¼šæœªçŸ¥ä½œè€…
- ğŸ·ï¸ **å…³é”®è¯**ï¼šcancerã€RNA-seqã€histone
- ğŸ“ **æè¿°**ï¼šContributors : Ola Hassan ; Mattia Pizzagalli ; Owen Leary ; John Zepecki ; Laura Jinxuan Wu ; Daniel Lee ; Lindsey R Howard ; Jorge E Fajardo ; Andras Fiser ; David Karambizi ; Nikos TapinosSeries Type : Expression profiling by high throughput sequencingOrganism : Homo sapiensClass IIa histone deacetylases (HDACs) are a family of enzymes that despite their name, do not have any measurable histone deacetylase activity but they function as multi-protein interaction hubs due to the presence of a prolonged N-terminal domain. Here we show that HDAC7, a member of the Class IIa HDAC family, is a chaperone for Histone H3.3 and, interacts with H3.3 and HIRA on chromatin. Specific inhibition of HDAC7 expression with subtype specific siRNAs results in inhibition of the interaction of H3.3 with HIRA, while the association of H3.3 with DAXX and H3K9me3 is significantly increased, resulting in H3.3 being deposited on H3K9me3+/DAPI+ heterochromatin nuclear foci with observed changes in RNA expression. This drives substantial alteration of cancer cell gene expression as well as inhibition of the stemness phenotype for cancer cells. To understand the genome wide effect on expression, we perform RNA-seq following HDAC7 knockdown.
- ğŸ”— [æŸ¥çœ‹åŸæ–‡](http://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE286177)

**5.** â­ **GSE286176 é€šè¿‡ HDAC7 ä»‹å¯¼çš„ç»„è›‹ç™½ H3.3 ç»“æ„é‡ç¼–ç¨‹åœ¨ç™Œç»†èƒä¸­æ‰©æ•£å¼‚æŸ“è‰²è´¨ [ChIP-seq]**
- âœï¸ **ä½œè€…**ï¼šæœªçŸ¥ä½œè€…
- ğŸ·ï¸ **å…³é”®è¯**ï¼šcancerã€ChIP-seqã€histone
- ğŸ“ **æè¿°**ï¼šContributors : Ola Hassan ; Mattia Pizzagalli ; Owen Leary ; John Zepecki ; Laura Jinxuan Wu ; Daniel Lee ; Lindsey R Howard ; Jorge E Fajardo ; Andras Fiser ; David Karambizi ; Nikos TapinosSeries Type : Genome binding/occupancy profiling by high throughput sequencingOrganism : Homo sapiensSpecific inhibition of HDAC7 expression with subtype specific siRNAs results in inhibition of the interaction of H3.3 with HIRA, while the association of H3.3 with DAXX and H3K9me3 is significantly increased, resulting in H3.3 being deposited on H3K9me3+/DAPI+ heterochromatin nuclear foci with observed changes in RNA expression. Inhibition of HDAC7 triggers a significant increase of heterochromatin marks H3K9me3 and H3K27me3, global heterochromatin spreading in cancer cells, and reprogramming of the H3.3 chromatin landscape. We performed H3K9me3 chip-seq in glioma stem cells following HDAC7 knockdown in order to identify specific sites of heterochromatin spreading and/or increased occupancy.
- ğŸ”— [æŸ¥çœ‹åŸæ–‡](http://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE286176)

**6.** **GSE314987 CSF3 é€šè¿‡ p65/NF-ÎºB ä¿¡å·é€šè·¯ä¿ƒè¿› TMEM74 è¡¨è¾¾å¹¶å¢å¼ºè‡ªå™¬ï¼Œä»è€Œé©±åŠ¨ç»“ç›´è‚ ç™Œè¿›å±•**
- âœï¸ **ä½œè€…**ï¼šæœªçŸ¥ä½œè€…
- ğŸ·ï¸ **å…³é”®è¯**ï¼šcancerã€pathway
- ğŸ“ **æè¿°**ï¼šContributors : Junfeng Xu ; Xinyan LiuSeries Type : Expression profiling by arrayOrganism : Homo sapiensCSF3 is overexpressed in CRC, correlating positively with poor patient prognosis.We want to find out the specific sets of genes are down-regulated.We used microarrays to detail the global programme of gene expression between HCT116 cells with Ctrl and CSF3 and identified distinct classes of down-regulated genes during this process.
- ğŸ”— [æŸ¥çœ‹åŸæ–‡](http://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE314987)

**7.** **GSE302019 æ‰¹é‡ RNA æµ‹åºï¼Œç”¨äºç ”ç©¶ä»é‡ç”Ÿå‹ C57BL/6J å’Œ Spp1-EGFP æ•²å…¥æŠ¥å‘ŠåŸºå› å°é¼ ä¸­åˆ†ç¦»çš„è‚ºå·¨å™¬ç»†èƒäºšç¾¤çš„è½¬å½•è°±ï¼Œè¿™äº›å°é¼ æ¥å—äº†æ°”ç®¡å†…æ³¨å°„åšæ¥éœ‰ç´ æˆ– PBSã€‚**
- âœï¸ **ä½œè€…**ï¼šæœªçŸ¥ä½œè€…
- ğŸ·ï¸ **å…³é”®è¯**ï¼šmacrophageã€sequencing
- ğŸ“ **æè¿°**ï¼šContributor : Kohsuke ShirakawaSeries Type : Expression profiling by high throughput sequencingOrganism : Mus musculusThis study aimed to characterize the transcriptomic landscape of Spp1-expressing interstitial macrophages (IMs) in the lungs of a bleomycin-induced pulmonary fibrosis mouse model using single-cell RNA sequencing (scRNA-seq). We utilized Spp1-EGFP knock-in reporter mice, in which EGFP marks Spp1-expressing cells. Pulmonary fibrosis was induced by intratracheal administration of bleomycin. Lung cells were isolated, and Spp1-EGFPâº SiglecFâ» CD11bâº interstitial macrophages were enriched by flow cytometric sorting. Approximately 10,000 viable sorted cells were processed for single-cell transcriptome profiling using the Chromium Next GEM Single Cell 3' Reagent Kits v3.1 (10x Genomics), and libraries were sequenced on a DNBSEQ-G400 platform. This dataset provides a high-resolution view of the cellular states and gene expression profiles of interstitial macrophages during lung fibrosis.
- ğŸ”— [æŸ¥çœ‹åŸæ–‡](http://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE302019)

**8.** **GSE290386 è‚¿ç˜¤æŠ‘åˆ¶ç´ Mé€šè¿‡ä¸­æ€§ç²’ç»†èƒä¾èµ–æ€§æœºåˆ¶é©±åŠ¨ç‰¹åº”æ€§çš®ç‚æ ·ç‚ç—‡çš„å¤šæ–¹é¢å…ç–«å‘ç—…æœºåˆ¶**
- âœï¸ **ä½œè€…**ï¼šæœªçŸ¥ä½œè€…
- ğŸ·ï¸ **å…³é”®è¯**ï¼šimmuneã€inflammation
- ğŸ“ **æè¿°**ï¼šContributors : YunJae Jung ; Minji Park ; Jin-Ok BaekSeries Type : Expression profiling by high throughput sequencingOrganism : Mus musculusAtopic dermatitis (AD) is a chronic inflammatory skin disease characterized by T helper 2 cell dysregulation and accumulation of innate immune cells. While recent studies have highlighted a role for neutrophils in the onset and progression of AD, their precise contributions remain incompletely defined. In a mouse model of AD-like inflammation induced by calcipotriol and ovalbumin, neutrophils were identified as a major source of the cytokine oncostatin M (OSM). Neutrophil-derived OSM promoted broad immune cell recruitment, exacerbated skin inflammation, and enhanced the expression of neuronal markers associated with pruritus. Knockdown of OSM and neutrophil depletion both attenuated inflammatory responses and neuronal activation. Publicly available single-cell RNA-sequencing datasets further confirmed increased OSM expression in neutrophils from lesional AD skin, underscoring the translational relevance of our findings. These results reveal a previously unrecognized intercellular communication axis in which neutrophil-derived OSM orchestrates multifaceted immune and neuroinflammatory responses in AD. Targeting this signaling pathway may offer a novel therapeutic avenue for AD and related inflammatory disorders.
- ğŸ”— [æŸ¥çœ‹åŸæ–‡](http://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE290386)

**9.** **GSE238259 Akr1b7 åœ¨åµå·¢è¡°è€ä¸­èµ·ç€å…³é”®è°ƒæ§ä½œç”¨ [RNA-seq]**
- âœï¸ **ä½œè€…**ï¼šæœªçŸ¥ä½œè€…
- ğŸ·ï¸ **å…³é”®è¯**ï¼šagingã€RNA-seq
- ğŸ“ **æè¿°**ï¼šContributors : Keishiro Isayama ; Kenji Watanabe ; Masato Ohtsuka ; Seisuke Kimura ; Tomoaki Murata ; Takeshi Honda ; Masataka Asagiri ; Shun Sato ; Hiroshi Tamura ; Norihiro Sugino ; Yoichi MizukamiSeries Type : Expression profiling by high throughput sequencingOrganism : Mus musculusAt the beginning of ovarian aging, the ovulation of immature oocytes is accelerated, finally leading to the arrest of ovulation despite the remaining oocytes. Here RNA expression in ovarian aging of mice is comprehensively analyzed during the estrous cycle after ovulation stimulation, and an aldo-keto reductase Akr1b7 pathway transiently increased in the young ovary is eliminated in the aged mice. Akr1b7-/- mice enhance the ovulation of immature oocytes, and the KITL expression in Akr1b7-expressed stromal is attenuated, accompanied by oocyte Akt essential for the follicular development inactivation in primordial follicles. The estrous cycle is extended due to the prolonged diestrous stage by a sustained progesterone level in Akr1b7-/- mice ovaries, which is caused by the decline of Cyp17a1, a major metabolite enzyme of progesterone in Akr1b7-expressed theca cell layers. Taken together, the decreased Akr1b7 pathway causes the ovulation of immature oocytes and the prolonged estrous cycle, typical symptoms of ovarian aging.
- ğŸ”— [æŸ¥çœ‹åŸæ–‡](http://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE238259)

**10.** **GSE315481 ç»„è›‹ç™½èµ–æ°¨é…¸ç”²åŸºåŒ–åŠ¨æ€è°ƒæ§ EGFR DNA æ‹·è´æ•°æ‰©å¢**
- âœï¸ **ä½œè€…**ï¼šæœªçŸ¥ä½œè€…
- ğŸ·ï¸ **å…³é”®è¯**ï¼šmethylationã€histone
- ğŸ“ **æè¿°**ï¼šContributors : Johnathan Whetstine ; Kashish Chetal ; Ruslan SadreyevSeries Type : Genome binding/occupancy profiling by high throughput sequencingOrganism : Homo sapiensAcquired chromosomal DNA copy gains are a feature of many tumors; however, the mechanisms that underpin oncogene amplifi cation are poorly understood. Recent studies have begun to uncover the importance of epigenetic states and histone lysine methyltrans_x0002_ferases (KMT) and demethylases (KDM) in regulating transient site-specifi c DNA copy-number gains (TSSG). In this study, we reveal a critical interplay between a myriad of lysine methyltransferases and demethylases in modulating H3K4/9/27 methylation balance to control extrachromosomal amplifi ca_x0002_tion of the EGFR oncogene. This study further establishes that cellular signals (hypoxia and EGF) are able to directly promote EGFR amplifi cation through modulation of the enzymes controlling EGFR copy gains. Moreover, we demonstrate that chemical inhibitors targeting specifi c KMTs and KDMs are able to promote or block extrachromosomal EGFR amplifi cation, which identifi es potential therapeu
- ğŸ”— [æŸ¥çœ‹åŸæ–‡](http://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE315481)

> ğŸ’¡ è¯¥æ¥æºè¿˜æœ‰ 36 æ¡å†…å®¹ï¼Œè¯¦è§ [æ–‡æœ«](#æ›´å¤š-æ•°æ®å‰æ²¿)

</div>

</details>

<details>
<summary style="text-align: right; direction: rtl; padding: 10px 15px; background: linear-gradient(135deg, #f8f9fa 0%, #e9ecef 100%); border-right: 4px solid #667eea; font-weight: 600; cursor: pointer; margin: 15px 0; border-radius: 6px;">ğŸ“Š å­¦ç‚¹ç”Ÿä¿¡ (1æ¡)</summary>

<div class="details-content" markdown="1">

#### è¯¦ç»†å†…å®¹ï¼ˆå…¨éƒ¨1æ¡ï¼‰

**1.** **LazyMouse â€“ ç”¨äºéšæœºç§»åŠ¨é¼ æ ‡å…‰æ ‡çš„ R åŒ…**
- âœï¸ **ä½œè€…**ï¼šæœªçŸ¥ä½œè€…
- ğŸ·ï¸ **å…³é”®è¯**ï¼šR package
- ğŸ“ **æè¿°**ï¼šNew R Package called LazyMouse with single function for randomly moving mouse cursor in your favorite R IDE. For every R developer, R data scientists and all those everyday R users, that also need a break and do not wantâ€¦Read more â€º Continue reading: LazyMouse â€“ R package for randomly moving mouse cursor
- ğŸ”— [æŸ¥çœ‹åŸæ–‡](https://www.r-bloggers.com/2026/01/lazymouse-r-package-for-randomly-moving-mouse-cursor/)


</div>

</details>

<details>
<summary style="text-align: right; direction: rtl; padding: 10px 15px; background: linear-gradient(135deg, #f8f9fa 0%, #e9ecef 100%); border-right: 4px solid #667eea; font-weight: 600; cursor: pointer; margin: 15px 0; border-radius: 6px;">ğŸ§ª åšå®¢æ›´æ–° (5æ¡)</summary>

<div class="details-content" markdown="1">

#### è¯¦ç»†å†…å®¹ï¼ˆå…¨éƒ¨5æ¡ï¼‰

**1.** **å£è…”ä¸­çš„æœ‰å®³ç»†èŒå¯èƒ½è¯±å‘å¸•é‡‘æ£®ç—…**
- âœï¸ **ä½œè€…**ï¼šæœªçŸ¥ä½œè€…
- ğŸ·ï¸ **å…³é”®è¯**ï¼šbacteriaã€regex:bacter(ia|ial|ium)
- ğŸ“ **æè¿°**ï¼šA familiar mouth bacterium best known for causing cavities may also be quietly influencing the brain. Scientists found that when this microbe settles in the gut, it produces compounds that can travel through the bloodstream and harm neurons involved in movement. In animal studies, this process triggered inflammation, motor problems, and brain changes linked to Parkinsonâ€™s disease. The findings hint that protecting oral and gut health could help protect the brain as well.
- ğŸ”— [æŸ¥çœ‹åŸæ–‡](https://www.sciencedaily.com/releases/2026/01/260106001916.htm)

**2.** **æ•´åˆå•ç»†èƒå¤šç»„å­¦æ•°æ®ï¼Œå°†é—ä¼ å˜å¼‚ä¸ç»†èƒç±»å‹è°ƒæ§ç½‘ç»œè¿æ¥èµ·æ¥**
- âœï¸ **ä½œè€…**ï¼šæœªçŸ¥ä½œè€…
- ğŸ·ï¸ **å…³é”®è¯**ï¼šsingle-cell
- ğŸ“ **æè¿°**ï¼šBy combining single-cell RNA sequencing with chromatin data and GWAS signals, scMORE links genetic variants to cell-specific regulatory networks, revealing aging and disease...
- ğŸ”— [æŸ¥çœ‹åŸæ–‡](https://www.rna-seqblog.com/integrating-single-cell-multiomics-to-link-genetic-variants-with-cell-type-regulatory-networks/)

**3.** **RNAå‰ªæ¥å’ŒåŠ å·¥æ˜¯äººç±»ç»„ç»‡è¡°è€çš„æ ¸å¿ƒç‰¹å¾ã€‚**
- âœï¸ **ä½œè€…**ï¼šæœªçŸ¥ä½œè€…
- ğŸ·ï¸ **å…³é”®è¯**ï¼šaging
- ğŸ“ **æè¿°**ï¼šBy combining RNA sequencing with network connectivity analysis, researchers uncover conserved age-related changes in RNA splicing and processing genes that are missed by expression analysis alone...
- ğŸ”— [æŸ¥çœ‹åŸæ–‡](https://www.rna-seqblog.com/rna-splicing-and-processing-emerge-as-central-features-of-human-aging-across-tissues/)

**4.** **å…¨çƒç™Œç—‡ç—…ä¾‹æ¿€å¢ï¼Œä¸–ç•Œå°šæœªåšå¥½å‡†å¤‡ã€‚**
- âœï¸ **ä½œè€…**ï¼šæœªçŸ¥ä½œè€…
- ğŸ·ï¸ **å…³é”®è¯**ï¼šcancer
- ğŸ“ **æè¿°**ï¼šGlobal cancer cases have surged dramatically, doubling since 1990 and reaching 18.5 million new diagnoses in 2023. Deaths have also climbed to over 10 million a year, with the steepest increases hitting low- and middle-income countries. Without urgent action, researchers project more than 30 million new cases annually by 2050. Alarmingly, around four in ten cancer deaths are tied to preventable risks such as smoking, poor diet, and high blood sugar.
- ğŸ”— [æŸ¥çœ‹åŸæ–‡](https://www.sciencedaily.com/releases/2026/01/260106224644.htm)

**5.** **ç£æ€§çº³ç±³ç²’å­å¯¹æŠ—éª¨ç™Œå¹¶ä¿ƒè¿›æ„ˆåˆ**
- âœï¸ **ä½œè€…**ï¼šæœªçŸ¥ä½œè€…
- ğŸ·ï¸ **å…³é”®è¯**ï¼šcancer
- ğŸ“ **æè¿°**ï¼šResearchers have developed a magnetic nanomaterial that can kill bone cancer cells and support bone regeneration at the same time. The material heats up under a magnetic field to destroy tumors, while its bioactive coating helps it bond to bone and stimulate healing. Tests showed rapid formation of bone-like minerals, a key sign of successful integration. The breakthrough could lead to smarter, less invasive treatments for bone tumors.
- ğŸ”— [æŸ¥çœ‹åŸæ–‡](https://www.sciencedaily.com/releases/2026/01/260106224627.htm)


</div>

</details>

## ğŸ“Š å…³é”®è¯ç»Ÿè®¡

| å…³é”®è¯ | å‡ºç°æ¬¡æ•° |
|--------|----------|
| cancer | 16 |
| RNA-seq | 11 |
| epigenetic | 7 |
| resistance | 5 |
| aging | 4 |
| ChIP-seq | 4 |
| histone | 4 |
| single-cell | 3 |
| regex:intestin(e|al) | 3 |
| pathway | 2 |
| macrophage | 2 |
| metabolic | 2 |
| R package | 1 |
| ATAC-seq | 1 |
| tumor | 1 |
| regex:immuno(logy|therapy|suppression) | 1 |
| spatial | 1 |
| spatial transcriptomics | 1 |
| transcriptomics | 1 |
| transcriptome | 1 |

---

## ğŸ“ æ›´å¤šå†…å®¹

<details>
<summary><a name="æ›´å¤š-æ•°æ®å‰æ²¿"></a>ğŸ§¬ æ•°æ®å‰æ²¿ å…¶ä»–å†…å®¹ (36æ¡)</summary>

<div class="details-content" markdown="1">

- [GSE315399 RNA-seq åˆ†æåµå·¢ç™Œç»†èƒç³» JHOC-5 å’Œ OVCA420 ä¸­ PRSS23 æ•²ä½çš„å½±å“](http://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE315399)
- [GSE315215 HAT1/p300-SIRT3 ä»‹å¯¼çš„èµ–æ°¨é…¸ä¸™é…®é…°åŒ–å°†ç³–é…µè§£é€šé‡ä¸è¡¨è§‚é—ä¼ è°ƒæ§è”ç³»èµ·æ¥ [RNA-seq]](http://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE315215)
- [GSE314136 Tfamä»‹å¯¼çš„RORgt+æ·‹å·´ç»†èƒä»£è°¢ç´Šä¹±å½±å“è‚ é“ç»„ç»‡ç¨³æ€å¹¶ä¿ƒè¿›GATA3+RORgt+å›ºæœ‰æ·‹å·´ç»†èƒ](http://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE314136)
- [GSE286178 é€šè¿‡ HDAC7 ä»‹å¯¼çš„ç»„è›‹ç™½ H3.3 ç»“æ„é‡ç¼–ç¨‹åœ¨ç™Œç»†èƒä¸­æ‰©æ•£å¼‚æŸ“è‰²è´¨](http://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE286178)
- [GSE271684 è¡¨è§‚é—ä¼ è°ƒæ§å› å­ BAP1 çš„ç ´åé©±åŠ¨æŸ“è‰²è´¨é‡å¡‘ï¼Œå¯¼è‡´å…·æœ‰ä¹³è…ºç™Œå¹²ç»†èƒç‰¹æ€§å’Œå¼‚å¸¸ç³–åŸºåŒ–çš„ç»†èƒå‡ºç° [gRNA_MiSeq]](http://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE271684)
- [GSE271683 è¡¨è§‚é—ä¼ è°ƒæ§å› å­ BAP1 çš„ç ´åé©±åŠ¨æŸ“è‰²è´¨é‡å¡‘ï¼Œå¯¼è‡´å…·æœ‰ä¹³è…ºç™Œå¹²ç»†èƒç‰¹æ€§å’Œå¼‚å¸¸ç³–åŸºåŒ–çš„ç»†èƒå‡ºç° [ChiPseq_2D]](http://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE271683)
- [GSE271682 è¡¨è§‚é—ä¼ è°ƒæ§å› å­ BAP1 çš„ç ´åé©±åŠ¨æŸ“è‰²è´¨é‡å¡‘ï¼Œå¯¼è‡´å…·æœ‰ä¹³è…ºç™Œå¹²ç»†èƒç‰¹æ€§å’Œå¼‚å¸¸ç³–åŸºåŒ–çš„ç»†èƒå‡ºç° [ATACseq_3D]](http://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE271682)
- [GSE271681 è¡¨è§‚é—ä¼ è°ƒæ§å› å­ BAP1 çš„ç ´åé©±åŠ¨æŸ“è‰²è´¨é‡å¡‘ï¼Œå¯¼è‡´å…·æœ‰ä¹³è…ºç™Œå¹²ç»†èƒç‰¹æ€§å’Œå¼‚å¸¸ç³–åŸºåŒ–çš„ç»†èƒå‡ºç° [RNAseq_3D]](http://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE271681)
- [GSE271680 è¡¨è§‚é—ä¼ è°ƒæ§å› å­ BAP1 çš„ç ´åé©±åŠ¨æŸ“è‰²è´¨é‡å¡‘ï¼Œå¯¼è‡´å…·æœ‰ä¹³è…ºç™Œå¹²ç»†èƒç‰¹æ€§å’Œå¼‚å¸¸ç³–åŸºåŒ–çš„ç»†èƒå‡ºç° [RNAseq_2D]](http://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE271680)
- [GSE260580 GATA4 è¢« CRL4B å¤åˆç‰©æ³›ç´ åŒ–ä»¥åˆºæ¿€æº¶é…¶ä½“å¹¶ä¿ƒè¿›åµå·¢ç™Œ EMT è¿‡ç¨‹ [ChIP-seq]](http://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE260580)
- [GSE259274 GATA4 æ³›ç´ åŒ–è¢« CRL4B å¤åˆç‰©æ¿€æ´»ï¼Œä»è€Œåˆºæ¿€æº¶é…¶ä½“å¹¶ä¿ƒè¿›åµå·¢ç™Œ EMT è¿‡ç¨‹ [RNA-seq]](http://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE259274)
- [GSE315692 å°æ ¸ä» RNA Snora61 é€šè¿‡å¯åŠ¨ Lgr5 è½¬å½•é©±åŠ¨å°è‚ å¹²ç»†èƒçš„è‡ªæˆ‘æ›´æ–°](http://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE315692)
- [GSE311314 KMT2A æ˜¯ IDH çªå˜å‹èƒ¶è´¨ç˜¤å‘ç”Ÿè¿‡ç¨‹ä¸­æ¶æ€§è½¬åŒ–çš„å…ˆå†³æ¡ä»¶ [RNA-Seq]](http://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE311314)
- [GSE309206 é«˜ç³–ç¯å¢ƒé€šè¿‡ ROS/Akt/ETV4 ä¿¡å·é€šè·¯æŸå®³è§’è´¨å½¢æˆç»†èƒçš„è¿ç§»å’Œå¢æ®–](http://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE309206)
- [GSE294900 æ˜Ÿå½¢èƒ¶è´¨ç»†èƒ Sox9 åœ¨é˜¿å°”èŒ¨æµ·é»˜ç—…æ¨¡å‹ä¸­ç»´æŒè®¤çŸ¥åŠŸèƒ½ [RNA-Seq]](http://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE294900)
- [GSE283858 KMT2A æ˜¯ IDH çªå˜å‹èƒ¶è´¨ç˜¤å‘ç”Ÿè¿‡ç¨‹ä¸­æ¶æ€§è½¬åŒ–çš„å…ˆå†³æ¡ä»¶ [RNA-Seq]](http://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE283858)
- [GSE269309 SRCAP å’Œ H2A.Z åŸºå› è°ƒæ§çš„æœºåˆ¶åŸºç¡€ï¼ˆRNA-Seqï¼‰](http://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE269309)
- [GSE269304 SRCAP å’Œ H2A.Z åŸºå› è°ƒæ§çš„æœºåˆ¶åŸºç¡€ï¼ˆChIP-Seqï¼‰](http://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE269304)
- [GSE269302 SRCAP å’Œ H2A.Z åŸºå› è°ƒæ§çš„æœºåˆ¶åŸºç¡€ (ATAC-Seq)](http://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE269302)
- [GSE310740 è°ƒèŠ‚ AP-1 å¯ä½¿ CAR-T ç»†èƒå»ºç«‹è‚¿ç˜¤å†…å¹²ç»†èƒæ ·å‚¨å­˜åº“å¹¶å…‹æœå¯¹ PD-1 é˜»æ–­çš„è€è¯æ€§](http://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE310740)
- [GSE310251 è°ƒèŠ‚ AP-1 å¯ä½¿ CAR-T ç»†èƒå»ºç«‹è‚¿ç˜¤å†…å¹²ç»†èƒæ ·å‚¨å­˜åº“å¹¶å…‹æœå¯¹ PD-1 é˜»æ–­çš„è€è¯æ€§](http://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE310251)
- [GSE310250 è°ƒèŠ‚ AP-1 å¯ä½¿ CAR-T ç»†èƒå»ºç«‹è‚¿ç˜¤å†…å¹²ç»†èƒæ ·å‚¨å­˜åº“å¹¶å…‹æœå¯¹ PD-1 é˜»æ–­çš„è€è¯æ€§](http://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE310250)
- [GSE310249 è°ƒèŠ‚AP-1å¯ä½¿CAR-Tç»†èƒå»ºç«‹è‚¿ç˜¤å†…å¹²ç»†èƒæ ·å‚¨å­˜åº“å¹¶å…‹æœå¯¹PD-1é˜»æ–­çš„è€è¯æ€§](http://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE310249)
- [GSE288687 è°ƒèŠ‚ AP-1 å¯ä½¿ CAR-T ç»†èƒå»ºç«‹è‚¿ç˜¤å†…å¹²ç»†èƒæ ·å‚¨å­˜åº“å¹¶å…‹æœå¯¹ PD-1 é˜»æ–­çš„è€è¯æ€§](http://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE288687)
- [GSE281556 ç ”ç©¶å‘ç°ï¼ŒPARPæŠ‘åˆ¶å‰‚åœ¨æº¶é…¶ä½“ä¸­çš„éš”ç¦»ä½œç”¨å¯å¯¼è‡´å…¶åœ¨åµå·¢ç™Œä¸­å¼‚è´¨æ€§ç§¯ç´¯ï¼Œä»è€Œæé«˜ç–—æ•ˆã€‚](http://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE281556)
- [GSE314816 å•ç»†èƒè§†è§’æ­ç¤ºé€‰æ‹©æ€§èƒå„¿ç”Ÿé•¿å—é™ä¸­æ»‹å…»å±‚å¼‚è´¨æ€§å’Œé€‚åº”æ€§åŠŸèƒ½éšœç¢](http://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE314816)
- [GSE307431 å«æœ‰2â€²-O-ç”²æ°§åŸºä¹™åŸºä¿®é¥°çš„æ²»ç–—æ€§åä¹‰å¯¡æ ¸è‹·é…¸å¯å¼•å‘è½¬å½•ç»„çš„ç‹¬ç‰¹æ‰°åŠ¨](http://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE307431)
- [GSE302018ï¼šSpp1-EGFPæŠ¥å‘ŠåŸºå› å°é¼ åšæ¥éœ‰ç´ è¯±å¯¼è‚ºçº¤ç»´åŒ–ä¸­è‚ºé—´è´¨å·¨å™¬ç»†èƒçš„å•ç»†èƒè½¬å½•ç»„åˆ†æ](http://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE302018)
- [GSE292269 èƒ½é‡ä»£è°¢ç´Šä¹±ä¸å¸¸æŸ“è‰²ä½“æ˜¾æ€§é—ä¼ æ€§è§†ç¥ç»èç¼©ä¸­çš„è§†ç½‘è†œç¥ç»èŠ‚ç»†èƒå˜æ€§ç›¸å…³](http://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE292269)
- [GSE238261 Akr1b7 åœ¨åµå·¢è¡°è€ä¸­å‘æŒ¥ç€å…³é”®è°ƒæ§ä½œç”¨](http://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE238261)
- [GSE238260 Akr1b7 åœ¨åµå·¢è¡°è€ä¸­èµ·ç€å…³é”®è°ƒæ§ä½œç”¨ [superSAGE]](http://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE238260)
- [GSE315216 HAT1/p300-SIRT3 ä»‹å¯¼çš„èµ–æ°¨é…¸ä¸™é…®é…°åŒ–å°†ç³–é…µè§£é€šé‡ä¸è¡¨è§‚é—ä¼ è°ƒæ§è”ç³»èµ·æ¥ [CUT&Tag]](http://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE315216)
- [GSE297767 é¶å‘ p63 äºšå‹è°ƒèŠ‚å¯çº æ­£ AEC ç»¼åˆå¾ä¸­çš„æ˜¾æ€§çªå˜ï¼Œè€Œä¸ç ´åè¡¨çš®ç¨³æ€ [äººç±» RNA-seq]](http://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE297767)
- [GSE297766 é¶å‘ p63 äºšå‹è°ƒèŠ‚å¯çº æ­£ AEC ç»¼åˆå¾ä¸­çš„æ˜¾æ€§çªå˜ï¼Œè€Œä¸ç ´åè¡¨çš®ç¨³æ€ [ChIP-seq]](http://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE297766)
- [GSE297765 é¶å‘ p63 äºšå‹è°ƒèŠ‚å¯çº æ­£ AEC ç»¼åˆå¾ä¸­çš„æ˜¾æ€§çªå˜ï¼Œè€Œä¸ç ´åè¡¨çš®ç¨³æ€ [RNA-seq å°é¼ ]](http://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE297765)
- [GSE285771 èƒ°ç®¡ç»†èƒä¸­çš„Orai1é€šè¿‡åˆ†æ³Œèƒ°æ¶²ä¸­çš„æŠ—èŒè‚½REG3Bä»‹å¯¼å®éªŒæ€§æ€¥æ€§èƒ°è…ºç‚ä¸­çš„èƒ°è‚ ç›¸äº’ä½œç”¨](http://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE285771)

</div>

</details>

---

*ğŸ“… æŠ¥å‘Šç”Ÿæˆæ—¶é—´ï¼š2026-01-07 21:39*  
*ğŸ¤– ç”± GitHub Actions è‡ªåŠ¨ç”Ÿæˆ*